FSR's Blog — Page 44 of 115 — Foundation for Sarcoidosis Research

Advancing how we Diagnose and Treat Sarcoidosis

Jan 22, 2020

Sarcoidosis is difficult to treat for many reasons. Mainly, there is not one clear way to treat sarcoidosis because it manifests in many forms and the cause is unknown. For this reason, there are also many ways to diagnose sarcoidosis, making it a diagnosis of...

Topics: Research

Dr. Nicholas Arger Receives ATS Foundation Research Program/Foundation for Sarcoidosis Partner Grant

Jan 9, 2020

(Jan. 9, 2020) — The ATS Foundation Research Program/Foundation for Sarcoidosis has awarded Nicholas Arger, MD, of the University of California, San Francisco a $80,000 Foundation Partner grant. The ATS Foundation Partner Grant provides crucial support to...

Topics: Other

aTyr Pharma Announces Positive Interim Safety Results from Ongoing Phase 1b/2a Clinical Trial of ATYR1923

Jan 9, 2020

FSR has partnered with aTyr Pharma, Inc. to help inform patients about an ongoing clinical trial for ATYR1923, a potential new treatment for pulmonary sarcoidosis (ATYR1923-C-002, NCT03824392.) aTyr recently issued a press release, republished with permission below,...

Topics: Research